Literature DB >> 2275888

Holter monitoring versus programmed ventricular stimulation.

M Borggrefe1, G Breithardt.   

Abstract

Both Holter monitoring and programmed ventricular stimulation are useful techniques for guiding antiarrhythmic therapy. However, they are not both appropriate for all patients. Holter monitoring is only useful in patients who have consistent and frequent ventricular ectopic beats, and programmed ventricular stimulation requires that the patients have an arrhythmia that is reproducible and inducible. Patients for whom these techniques are used to identify agents that are effective for control of their arrhythmias generally have a better prognosis than those patients for whom an effective agent is not found. Programmed ventricular stimulation may have a better predictive value than Holter monitoring, but the comparison may not be valid, because the procedures are used in different types of patients.

Entities:  

Mesh:

Year:  1990        PMID: 2275888     DOI: 10.1007/bf00357029

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  8 in total

1.  Is programmed stimulation of value in predicting the long-term success of antiarrhythmic therapy for ventricular tachycardias?

Authors:  S G Kim; S W Seiden; S D Felder; L E Waspe; J D Fisher
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Predictive value of electrophysiologic testing in the treatment of drug-refractory ventricular arrhythmias with amiodarone.

Authors:  M Borggrefe; G Breithardt
Journal:  Eur Heart J       Date:  1986-09       Impact factor: 29.983

3.  Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias.

Authors:  M Borggrefe; H J Trampisch; G Breithardt
Journal:  J Am Coll Cardiol       Date:  1988-07       Impact factor: 24.094

4.  Survivors of cardiac arrest: prevention of recurrence by drug therapy as predicted by electrophysiologic testing or electrocardiographic monitoring.

Authors:  B T Skale; W M Miles; J J Heger; D P Zipes; E N Prystowsky
Journal:  Am J Cardiol       Date:  1986-01-01       Impact factor: 2.778

5.  Long-term survival of patients with malignant ventricular arrhythmia treated with antiarrhythmic drugs.

Authors:  T B Graboys; B Lown; P J Podrid; R DeSilva
Journal:  Am J Cardiol       Date:  1982-09       Impact factor: 2.778

6.  Arrhythmia control and other factors related to sudden death in coronary disease patients at intermediate risk.

Authors:  R D Blevins; N Z Kerin; H Frumin; K Faitel; R Jarandilla; C Garfinkel; M Rubenfire
Journal:  Am Heart J       Date:  1986-04       Impact factor: 4.749

7.  Comparison of programmed electrical stimulation and ambulatory electrocardiographic (Holter) monitoring in the management of ventricular tachycardia and ventricular fibrillation.

Authors:  E V Platia; P R Reid
Journal:  J Am Coll Cardiol       Date:  1984-09       Impact factor: 24.094

8.  Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease.

Authors:  L N Horowitz; A M Greenspan; S R Spielman; C R Webb; J Morganroth; H Rotmensch; N M Sokoloff; A P Rae; B L Segal; H R Kay
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.